AG
SYNH

Aperio Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Aperio Group’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2.29M Buy
33,658
+16,339
+94% +$1.02M 0.01% 1178
2020
Q3 		$921K Buy
17,319
+358
+2% +$21.3K ﹤0.01% 1478
2020
Q2 		$988K Sell
16,961
-1,012
-6% -$54.4K ﹤0.01% 1414
2020
Q1 		$708K Buy
17,973
+5,442
+43% +$318K ﹤0.01% 1460
2019
Q4 		$745K Sell
12,531
-224
-2% -$12K ﹤0.01% 1603
2019
Q3 		$679K Buy
12,755
+2,371
+23% +$122K ﹤0.01% 1594
2019
Q2 		$531K Buy
10,384
+2,511
+32% +$117K ﹤0.01% 1759
2019
Q1 		$408K Buy
7,873
+484
+7% +$23.5K ﹤0.01% 1862
2018
Q4 		$291K Buy
7,389
+678
+10% +$31.5K ﹤0.01% 1964
2018
Q3 		$346K Buy
6,711
+74
+1% +$3.62K ﹤0.01% 1950
2018
Q2 		$311K Sell
6,637
-524
-7% -$21.7K ﹤0.01% 1981
2018
Q1 		$254K Sell
7,161
-8,097
-53% -$317K ﹤0.01% 2035
2017
Q4 		$665K Buy
15,258
+4,699
+45% +$220K ﹤0.01% 1562
2017
Q3 		$552K Sell
10,559
-1,143
-10% -$63.7K ﹤0.01% 1602
2017
Q2 		$685K Buy
+11,702
New +$608K ﹤0.01% 1457

Other funds holding SYNH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Aperio Group's SYNH Position: Q4 2020 in Review

Aperio Group increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 94% in Q4 2020, buying an estimated $1.02M and bringing the position to 33,658 shares worth $2.29M. The position accounts for 0.01% of the portfolio, ranked #1178.

Aperio Group first reported a position in SYNH in Q2 2017 and has held it in 15 quarters since. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

  • Aperio Group held 33,658 shares of Syneos Health, Inc. Class A Common Stock worth $2.29M as of Q4 2020.
  • Aperio Group bought 16,339 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $1.02M.
  • Syneos Health, Inc. Class A Common Stock made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1178 holding.
  • Aperio Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and has held it in 15 quarters since.
  • 313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.